R. Luisi et al.
1
Enantiomeric purity (e.r.>98:2) ascertained by H NMR spectroscopy in
ACHTUNGTRENNUNG
the presence of Mosherꢂs acid (see the Supporting Information).
General procedure for the lithiation–trapping sequence of aziridines
(S,S)-1c at 08C: sBuLi (1.5 mmol, 1.4m cyclohexane solution) was added
dropwise to a solution of aziridine (1 mmol) and TMEDA (1.5 mmol) in
Et2O (10 mL) at 08C and under an N2 atmosphere. The resulting orange
mixture was stirred for 3.5 h before adding the electrophile (neat if liquid
or diluted in 2 mL of Et2O if solid). Then a solution of sat. aq. NH4Cl
(3 mL) was added and the mixture poured into water (20 mL) and ex-
tracted with Et2O (3ꢃ10 mL). The combined organic layers were dried
(Na2SO4) and the solvent evaporated in vacuo. The crude was purified by
flash chromatography on silica gel (EtOAc/petroleum ether).
3J
major; ArH), 7.29–7.35 (m, 1 H major + 2 H minor; ArH), 7.18–7.21
(m, 2H, major; ArH), 7.14 (d, 3J
(H,H)=7.0 Hz, 1H, minor; ArH), 2.96
(d, 3J
(H,H)=2.9 Hz, 1H, minor; ArCHN), 2.56 (s, 3H, major; NCH3),
2.28 (d, J
NCHCH3), 2.03–2.06 (m, 1H, major; NCHCH3), 2.01 (s, 3H, minor;
NCH3), 1.39 (d, 3J
(H,H)=5.8 Hz, 3H, major; CHCH3), 1.34 (d,
3J
ACTHNGUTREN(NUG H,H)=5.3 Hz, 3H, minor; CHCH3), 0.40 (s, 9H, minor; 3ꢃCH3),
(H,H)=7.0 Hz, 1H, minor; ArH), 7.46 (d, 3J
ACHUTGTNRENNUG ACHUTNTGREN(NUGN H,H)=7.2 Hz, 1H,
AHCTUNGTRENNUNG
AHCTUNGTRENNUNG
3
AHCTUNGTREG(NNNU H,H)=2.8 Hz, 1H, major; ArCHN), 2.17–2.21 (m, 1H, minor;
AHCTUNGTRENNUNG
0.36 ppm (s, 9H, major; 3ꢃCH3); 13C NMR (spectra description for the
major invertomer, 150 MHz, CDCl3, 263 K): d=145.9, 137.5, 133.8, 129.6,
125.7, 123.7, 49.4, 43.5, 38.4, 11.0, 0.4 ppm; IR (film): n˜ =620, 741, 837,
ACHTUNGTRENNUNG(2R,3S)-1,3-Dimethyl-2-trimethylsilyl-2-phenylaziridine (cis-5c): Flash
chromatography (petroleum ether/EtOAc 40:60), colourless oil, 65%.
[a]2D0 =À66 (c=1, CHCl3); 1H NMR (400 MHz, CDCl3, 298 K): d=7.17–
7.21 (m, 2H; ArH); 7.06–7.11 (m, 3H; ArH), 2.74 (s, 3H; NCH3), 1.88
1087, 1121, 1249, 1398, 1438, 1466, 2955, 3053 cmÀ1
; MS (70 eV):
m/z (%): 219 (19) [M+], 218 (81) [M+ÀH], 205 (15), 204 (87), 147 (16),
146 (100) [M+ÀSiCH3], 145 (24), 144 (14), 131 (19), 73 (41) [SiCH3+];
ESI-MS: m/z (%): 220 (100) [M+H]+. Enantiomeric purity (e.r.>98:2)
ascertained by 1H NMR spectroscopy in the presence of Mosherꢂs acid
(see the Supporting Information).
(q, 3J(H,H)=5.6 Hz, 1H; CHCH3), 0.92 (d, 3J
ACHTUNGTRENNUNG ACHTUNTGREN(NUGN H,H)=5.6 Hz, 3H;
CHCH3), 0.03 ppm (s, 9H; 3ꢃCH3); 13C NMR (100 MHz, CDCl3, 298 K):
d=141.6, 129.4, 127.5, 125.3, 44.4, 43.5, 16.2, 0.2 ppm; IR (film): n˜ =702,
837, 884, 1249, 1453, 1488, 2952, 3024, 3056 cmÀ1; MS (70 eV): m/z (%):
219 (24) [M+], 218 (100) [M+ÀH], 204 (14), 135 (18), 105 (27), 73 (37).
Enantiomeric purity determined by HPLC analysis (Daicel Chiralcel
OD-H column, hexane/iPrOH 99:1, flow rate 0.4 mLminÀ1, l=220 nm;
for racemic aziridine, t1 =10.33 min, t2 =10.85 min; for enantioenriched
aziridine, t=10.49 min).
(1R,2’S,3’S)-4-Chlorophenyl-[2-(1,3-dimethylaziridin-2-yl)phenyl]metha-
nol (diast-10c): Flash chromatography (petroleum ether/EtOAc 20:80),
colourless oil, 23% as inseparable mixture of invertomers (d.r.=87:13,
CDCl3, 298 K). [a]2D0 =+99 (c=2 in CHCl3); 1H NMR (400 MHz, CDCl3,
298 K): d=7.17–7.29 (m, 8H, major; ArH), 7.07–7.16 (m, 7H, minor;
ArH), 6.87–6.89 (m, 1H, minor; ArH), 6.17 (s, 1H, minor; CHOH), 5.60
(1R,2’S,3’S)-4-Chlorophenyl-(1,3-dimethyl-2-phenylaziridin-2-yl)methanol
(9c): Flash chromatography (petroleum ether/EtOAc 80:20), white solid,
35%. M.p. 113.0–114.08C; [a]2D0 =+22 (c=0.9 in CHCl3); 1H NMR
(600 MHz, CDCl3, 298 K): d=7.32–7.33 (m, 3H; ArH), 7.14–71.5 (m,
(s, 1H, major; CHOH), 3.28 (d, 3J
2.04 (d, 3J
(H,H)=3.3 Hz, 1H, major; ArCHN), 1.94–2.00 (m, 1H
major+1H minor; 2ꢃCH3CHN), 1.90 (s, 3H, major; NCH3), 1.67 (s, 3H,
minor; NCH3), 1.31 (d, 3J
(H,H)=4.4 Hz, 3H, minor; CHCH3), 1.20 ppm
(d, 3J(H,H)=6.0 Hz, 3H, major; CHCH3); 13C NMR (spectra description
ACHTUNGTRNE(NUNG H,H)=4.0 Hz, 1H, minor; ArCHN),
AHCTUNGTRENNUNG
4H; ArH), 7.01 (d, 3J
2.13 (s, 3H; NCH), 2.00 (q, J
3J(H,H)=6.0 Hz, 3H; CHCH3); 13C NMR (100 MHz, CDCl3, 298 K): d=
ACHTUNGTRENNUNG(H,H)=8.3 Hz, 2H; ArH), 5.07 (s, 1H; CHOH),
AHCTUNGTRENNUNG
3
AHCTUNGTERG(NUNN H,H)=6.0 Hz, 1H; CHCH3), 1.35 ppm (d,
AHCTUNGTRENNUNG
ACHTUNGTRENNUNG
for both the invertomers, 100 MHz, CDCl3, 298 K): d=143.3, 142.3,
140.9, 138.3, 137.9, 132.5, 130.0, 129.45, 129.4, 128.7, 128.2, 128.1, 127.94,
127.92, 127.8, 127.1, 122.3, 121.3, 84.4, 84.2, 75.8, 57.8, 48.6, 39.9, 36.7,
29.7, 14.6, 10.9 ppm; IR (film): n˜ =759, 1013, 1032, 1088, 1171, 1263,
1377, 1402, 1457, 1488, 1601, 2850, 2920, 2957, 3413 cmÀ1; ESI-MS: m/z
(%): 288 (100) [M+H]+.
139.8, 136.7, 132.4, 131.6, 128.2, 128.1, 127.7, 74.2, 54.8, 45.2, 40.9,
14.0 ppm; IR (KBr): n˜ =704, 730, 828, 1014, 1075, 1090, 1131, 1405, 1446,
1490, 2870, 2924, 2956, 3059, 3368 cmÀ1; ESI-MS: m/z (%): 288 (100)
[MÀH]+; elemental analysis calcd (%) for C17H18ClNO: C 70.95, N 4.87,
H 6.30; found: C 70.54, N 4.85, H 6.28. Enantiomeric purity determined
by HPLC analysis (Cellulose Lux-2, hexane/iPrOH 90:10, flow rate
0.8 mLminÀ1
, l=260 nm; for racemic aziridine, t1 =6.13 min, t2 =
7.18 min; for enantioenriched aziridine, t=6.17 min).
(1S,2’S,3’S)-4-Chlorophenyl-[2-(1,3-dimethylaziridin-2-yl)phenyl]metha-
nol (10c): Flash chromatography (petroleum ether/EtOAc 20:80), white
solid, 28% as inseparable mixture of invertomers (d.r.=77:23, CDCl3,
298 K). M.p. 140.0–141.08C; [a]2D0 =+23 (c=1.2 in CHCl3); 1H NMR
(400 MHz, CDCl3, 298 K): d=7.10–7.35 (m, 15H, major+minor; ArH),
7.03–7.06 (m, 1H, major; ArH), 6.08 (s, 1H, major; CHOH), 5.86 (s, 1H,
(1S,2’S,3’S)-4-Chlorophenyl-(1,3-dimethyl-2-phenylaziridin-2-yl)methanol
(diast-9c): Flash chromatography (petroleum ether/EtOAc 80:20),white
solid, 35%. M.p. 184.0–185.08C; [a]2D0 =+39 (c=1.9 in CHCl3); 1H NMR
(600 MHz, CDCl3, 298 K): d=7.19–7.28 (m, 5H; ArH), 7.11 (d,
minor; CHOH), 2.78 (d, 3J
3H, major; NCH3), 2.31 (d, 3J
(s, 3H, minor; NCH3), 2.00–2.06 (m, 1H major+1H minor; NCHCH3),
1.38 (d, 3J(H,H)=5.5 Hz, 3H, minor; CHCH3), 1.32 ppm (d, 3J
(H,H)=
ACHTUNGTRENNUNG
3J(H,H)=8.4 Hz, 2H; ArH), 6.99 (d, 3J
ACHTUNGTRENNUNG ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
A
ACHTUNGTRENNUNG
CHCH3); 13C NMR (100 MHz, CDCl3, 298 K): d=140.1, 134.5, 132.3,
132.0, 127.7, 127.5, 127.4, 74.3, 56.9, 47.2, 42.2, 14.6 ppm; IR (KBr): n˜ =
704, 730, 1014, 1050, 1066, 1090, 1404, 1447, 1490, 2852, 2921, 2955,
3086 cmÀ1; ESI-MS: m/z (%): 288 (100) [M+H]+; elemental analysis
calcd (%) for C17H18ClNO: C 70.95, N 4.87, H 6.30; found: C 70.54, N
4.85, H 6.28. Enantiomeric purity determined by HPLC analysis (Cellu-
lose Lux-2, hexane/iPrOH 90:10, flow rate 0.8 mLminÀ1, l=260 nm; for
racemic aziridine, t1 =6.53 min, t2 =7.01 min; for enantioenriched aziri-
dine, t=6.94 min).
A
ACHTUNGTRENNUNG
6.0 Hz, 3H, major; CHCH3); 13C NMR (spectra description for both the
invertomers, 100 MHz, CDCl3, 298 K): d=145.2, 143.3, 143.2, 141.1,
137.6, 132.8, 132.6, 130.5, 130.1, 128.6, 128.4, 128.3, 128.2, 128.1, 127.8,
127.5, 127.3, 127.24, 127.2, 126.8, 71.9, 69.8, 48.1, 45.6, 40.8, 39.1, 39.0,
37.8, 17.6, 10.8 ppm; ESI-MS: m/z (%): 288 (100) [M+H]+; IR (KBr):
n˜ =759, 1014, 1033, 1089, 1457, 1488, 2850, 2920, 3420 cmÀ1. Enantiomeric
purity determined by HPLC analysis (Cellulose Lux-2, hexane/iPrOH
90:10, flow rate 0.8 mLminÀ1, l=260 nm; for racemic aziridine, t1 =
10.53 min, t2 =15.42 min; for enantioenriched aziridine, t=10.42 min).
General procedure for the lithiation–trapping sequence of aziridines
(S,S)-1c at À788C: sBuLi (1.5 mmol of a 1.4m cyclohexane solution) was
added dropwise to a solution of aziridine (1 mmol) in dry THF (10 mL)
at À788C and under an N2 atmosphere. The resulting brown mixture was
stirred for 4 h before adding the electrophile (neat if liquid or diluted in
2 mL of THF if solid). The mixture was stirred at À788C until consump-
tion of the starting aziridine (TLC-GC monitoring) and then warmed up
to room temperature. A solution of sat. aq. NH4Cl (3 mL) was added, the
mixture poured into water (20 mL), and then extracted with Et2O (3ꢃ
10 mL). The combined organic layers were dried (Na2SO4) and the sol-
vent evaporated in vacuo. The crude was purified by flash chromatogra-
phy on silica gel (EtOAc/petroleum ether) or by crystallisation.
General procedure for the reductive ring-opening of substituted aziri-
dines: Pd(OH)2 (20mol%) was added to a solution of aziridine (1 mmol)
in EtOAc or MeOH (1 mL). The mixture was connected with a cannula
to a balloon filled with hydrogen at room temperature and stirred until
consumption of the starting aziridine (TLC-GC monitoring). The reac-
tion mixture was filtered on a celite pad and concentrated in vacuo. The
crude was purified by chromatography on silica gel or by crystallisation.
(R)-1,2-Diphenyl-N-propylbutan-2-amine (11a): Flash chromatography
(petroleum ether/EtOAc, 90:10), pale yellow oil, 81%. [a]2D0 =+14 (c=1
in CHCl3); 1H NMR (400 MHz, CDCl3, 298 K): d=7.23–7.29 (m, 4H;
ArH), 7.16–7.19 (m, 1H; ArH), 7.09–7.10 (m, 3H; ArH), 6.70–6.72 (m,
294
ꢁ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2011, 17, 286 – 296